Table 3

Adjusted ORs (95% CI) of matched patients 2009–2013

Warfarin group
(n=448)
Non-warfarin group (n=448)p ValueAdjusted OR (95% CI)
30-day mortality99 (22%)73 (16%)0.0031.94 (1.25 to 3.01)
Head injury170 (38%)156 (35%)0.1341.41 (0.90 to 2.21)
Specialist neuro centre270 (60%)157 (35%)<0.0013.09 (2.28 to 4.20)